why choose us

First received: August 17, 2022

Clinical Trial: Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

Study Status: Completed

Recruit Status: RECRUITING

Condition: SIOD

Study Type: INTERVENTIONAL


Official Title: Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCR??+ T-cell/CD19+ B-cell Depletion for Patient

Brief Summary: This is a single center, non-randomized, non-controlled open-label phase 1b/2a trial of performing sequential ??depleted-HSCT and KT in patients requiring KT to prevent kidney rejection post-KT, in the absence of any post-KT immunosuppression, to abrogate the need for lifelong immunosuppression, the risk of chronic rejection and, ultimately, the need for repeated transplantation.

Read more